Últimos Artículos de Lancet Diabetes & Endocrinology
- [Personal View] Tight versus liberal blood-glucose control in the intensive care unit: special considerations for patients with diabetes
- [Correspondence] Bridging the worlds of research and policy making
- [Correspondence] Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation
- [Correspondence] Evaluating the effect of bempedoic acid on kidney function: call for cautious implementation – Authors' reply
- [Editorial] Undiagnosed type 2 diabetes: an invisible risk factor
- [Articles] Duration of fracture prevention after zoledronate treatment in women with osteopenia: observational follow-up of a 6-year randomised controlled trial to 10 years
- [In Focus] Bariatric tourism
- [Comment] Optimising zoledronate treatment holiday duration without loss of fracture prevention
- [Articles] Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study
- [Comment] Long-term trial outcomes of Roux-en-Y gastric bypass and one anastomosis gastric bypass: tipping the scale
- [Articles] Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres
- [Comment] Reversibility of congenital hypogonadotropic hypogonadism: lessons from a rare disease
- [Comment] Type 2 diabetes remission: weight maintenance in the spotlight
- [Comment] CONCEPTT to care: the science of implementation in diabetes care
- [Articles] 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study
- [Comment] Thank you to The Lancet Diabetes & Endocrinology's statistical and peer reviewers in 2023
- [Correspondence] Milestone achievement for global access to blood glucose meters and test strips
- [Comment] Living between two worlds: lessons for community involvement
- [Comment] Denosumab in the treatment of osteoporosis associated with chronic kidney disease
- [Editorial] Women in science: inspiring future generations